Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life.
Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life.
复制标题
DOI:
10.1007/s40258-023-00810-y
复制
发表时间:
2023-09
影响因子:
3.6
通讯作者:
Petrou, Stavros
中科院分区:
文献类型:
--
作者:
Alacevich, Caterina;Thalmann, Inna;Nicodemo, Catia;de Lusignan, Simon;Petrou, Stavros
Understanding the physical and mental health needs of the population through evidence-based research is a priority for informing health policy. During the COVID-19 pandemic, population wellbeing dramatically dropped. The relationship between experiences of symptomatic illness episodes and health-related quality of life has been less documented. This study analysed the association between symptomatic COVID-19 illness and health-related quality of life. The analyses drew from a cross-sectional analysis of data from a national digital symptoms’ surveillance survey conducted in the UK in 2020. We identified illness episodes using symptoms and test results data and we analysed validated health-related quality of life outcomes including health utility scores (indexed on a 0–1 cardinal scale) and visual analogue scale (VAS) scores (0–100 scale) generated by the EuroQoL’s EQ-5D-5L measure. The econometric model controlled for respondents’ demographic and socioeconomic characteristics, comorbidities, social isolation measures, and regional and time fixed effects. The results showed that the experience of common SARS-CoV-2 symptoms was significantly associated with poorer health-related quality of life across all EQ-5D-5L dimensions of mobility, self-care, usual activities, pain/discomfort and anxiety/depression, a decrement in utility score of − 0.13 and a decrement in the EQ-VAS score of − 15. The findings were robust to sensitivity analyses and restrictive test results-based definitions. This evidence-based study highlights the need for targeting of interventions and services towards those experiencing symptomatic episodes during future waves of the pandemic and helps to quantify the benefits of SARS-CoV-2 treatment in terms of health-related quality of life. The online version contains supplementary material available at 10.1007/s40258-023-00810-y.
登录
查看更多内容
影响因子:
4.6
作者:
Alacevich, Caterina;Thalmann, Inna;Nicodemo, Catia;de Lusignan, Simon;Petrou, Stavros
通讯作者:
Petrou, Stavros
DOI:
10.3390/ijerph18030847
发表时间:
2021-01-20
影响因子:
--
作者:
Algahtani FD;Hassan SU;Alsaif B;Zrieq R
通讯作者:
Zrieq R
影响因子:
3.7
作者:
Bilcke, Joke;Coenen, Samuel;Beutels, Philippe
通讯作者:
Beutels, Philippe
影响因子:
105.7
作者:
Kind, P;Dolan, P;Williams, A
通讯作者:
Williams, A
影响因子:
3.5
作者:
Herdman, M.;Gudex, C.;Lloyd, A.;Janssen, M. F.;Kind, P.;Parkin, D.;Bonsel, G.;Badia, X.
通讯作者:
Badia, X.